Lifeward strategic moves amid revenue decline

Lifeward reports Q1 2026 revenue decline but gains investor confidence through strategic acquisitions. Read more on Bond.az.

ByMia Lopez- Senior Editor

Today / 13:13|Last updated: Today / 13:14

Lifeward strategic moves amid revenue decline — Photo: Prepared by Bond.az

Lifeward Ltd (LFWD) reported a 22% revenue drop in Q1 2026 to $3.9 million, but shares rose 1.29% premarket.

CEO Mark Grant highlighted the strategic acquisition of Oratech, which transforms Lifeward into a diversified biomedical innovation company.

Despite temporary disruptions in AlterG shipments, ReWalk exoskeleton sales grew 11%. Lifeward expects 2026 revenue to be similar to 2025.

More News

MiNK Therapeutics Q1 2026: Strategic Progress

Today / 13:51

926

MiNK Therapeutics Q1 2026: Strategic Progress

MiNK Therapeutics Q1 2026 earnings: strategic progress, financial results, and updates on AGENT-797 platform.

TRANSCRIPTS →

Today / 13:24

926

Kepler Weber Q1 2026: Mixed Results

Kepler Weber reported mixed Q1 2026 results with international growth offsetting domestic declines. EBITDA margin stable at 11%.

TRANSCRIPTS →

Acumen Pharmaceuticals Beats Q1 2026 EPS Forecast

Today / 13:22

694

Acumen Pharmaceuticals Beats Q1 2026 EPS Forecast

Acumen Pharmaceuticals beats Q1 2026 EPS forecast with -$0.33, but stock falls on cautious sentiment. Details on ALTITUDE-ad trial and EBD program.

TRANSCRIPTS →

Today / 13:21

213

Alico Beats Q2 2026 EPS Forecast by 23%

Alico (ALCO) reports Q2 fiscal 2026 EPS of $1.49, beating estimates by 23%. The company pivots from citrus to land monetization, boosting profitability.

TRANSCRIPTS →

PAVmed Q1 2026: Restructuring Gains Highlighted

Today / 13:20

536

PAVmed Q1 2026: Restructuring Gains Highlighted

PAVmed Inc. reported Q1 2026 results with restructuring gains and product development progress. Stock up 3.1%.

TRANSCRIPTS →

Friedrich Vorwerk Q1 2026: Strong Results, Stock Drops

Today / 13:10

236

Friedrich Vorwerk Q1 2026: Strong Results, Stock Drops

Friedrich Vorwerk Q1 2026 results: strong financials, stock drop. Growth expected in hydrogen and energy transition.

TRANSCRIPTS →

Exodus Q1 2026 earnings: mixed results revealed

Today / 12:01

484

Exodus Q1 2026 earnings: mixed results revealed

Exodus Movement Q1 2026 results mixed: EPS beat but revenue miss. Stock falls 14.79% after hours.

TRANSCRIPTS →

Galapagos NV Revenue Drops 91% in Q1 2026

Today / 09:34

540

Galapagos NV Revenue Drops 91% in Q1 2026

Galapagos NV reports 91% revenue drop in Q1 2026 but achieves net profit. Details on transformation and gamgertamig potential.

TRANSCRIPTS →

KT Corp Q1 2026 Earnings Miss Expectations

Today / 09:33

271

KT Corp Q1 2026 Earnings Miss Expectations

KT Corporation Q1 2026 earnings miss estimates. EPS $0.4948 vs $0.5325 forecast. Stock down 3.43%. Company shifts to AI-driven AX platform strategy.

TRANSCRIPTS →

Multiconsult Q1 2026 misses EPS expectations

Today / 09:27

700

Multiconsult Q1 2026 misses EPS expectations

Multiconsult Q1 2026 results: EPS misses expectations, revenue slightly below forecasts, stock price dips modestly.

TRANSCRIPTS →

Village Farms Q1 2026 Shows Strong Revenue Growth

Today / 09:04

728

Village Farms Q1 2026 Shows Strong Revenue Growth

Village Farms Q1 2026 results: EPS met, revenue beat. Cannabis sales up 27%. Stock rises 3.89% in pre-market. Strong financial health per Bond.az.

TRANSCRIPTS →

Eisai Q4 2025: Record Revenue, Profit Declines

Today / 09:03

946

Eisai Q4 2025: Record Revenue, Profit Declines

Eisai Q4 2025 financial results: record revenue but profit declines. Analysis of LEQEMBI, DAYVIGO, and LENVIMA performance.

TRANSCRIPTS →

...